High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.

被引：0
|
作者：
Kaiser, S [1 ]
Kreysel, C [1 ]
Hass, H [1 ]
Gregor, M [1 ]
机构：
[1] Univ Tubingen Hosp, Tubingen, Germany
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1639
引用
收藏
页码：582A / 582A
页数：1
相关论文
共 50 条
  • [31] Comparison of peginterferon plus ribavirin with or without induction therapy for the treatment of chronic hepatitis C (HCV) non-responders
    Bzowej, N
    Gish, R
    Wakil, AED
    Brooks, L
    Shaffer, M
    Temkin, SKA
    Leung, J
    GASTROENTEROLOGY, 2002, 123 (01) : 76 - 76
  • [32] High sustained response to daily dosing of interferon with ribavirin in chronic hepatitis C patients naive to therapy
    Abbas, Z
    Hamid, S
    Tabassum, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (05) : 577 - 581
  • [33] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive patients with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Gregor, M
    HEPATOLOGY, 2000, 32 (04) : 561A - 561A
  • [34] Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
    McHutchison, JG
    Poynard, T
    SEMINARS IN LIVER DISEASE, 1999, 19 : 57 - 65
  • [35] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [36] Ribavirin levels and haemoglobin decline in early virological responders and non-responders to hepatitis C virus combination therapy
    Donnerer, J
    Grahovac, M
    Stelzl, E
    Kessler, HH
    Bankuti, C
    Stadlbauer, V
    Stauber, RE
    PHARMACOLOGY, 2006, 76 (03) : 136 - 140
  • [37] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [38] Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin
    Hassanein, Tarek
    Ghalib, Reem H.
    Zein, Nizar N.
    Rothstein, Kenneth D.
    Joshi, Shobha N.
    Kwo, Paul Yien
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 824A - 824A
  • [39] Tolerance to pegylated interferon maintenance therapy in patients with chronic hepatitis C who are non-responders to standard combination therapy.
    Selim, K
    Behling, C
    Lyche, KD
    Winston, DH
    Rossi, SJ
    Wahlstrom, EH
    Hyun, CB
    Jensen, JE
    Babich, MM
    Nguyen, TT
    Stewart, MA
    Myers, WY
    Ziegler, EA
    Oliver, DL
    Hassanein, TI
    HEPATOLOGY, 2002, 36 (04) : 574A - 574A
  • [40] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
12345